Inhibikase Therapeutics, Inc. (IKT)
2.43
0.00 (0.00%)
USD |
NASDAQ |
Sep 09, 11:41
Inhibikase Therapeutics Market Cap : 320.84M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 320.84M |
| September 04, 2026 | 330.08M |
| September 03, 2026 | 332.72M |
| September 02, 2026 | 330.08M |
| September 01, 2026 | 314.24M |
| August 31, 2026 | 305.00M |
| August 28, 2026 | 318.20M |
| August 27, 2026 | 326.12M |
| August 26, 2026 | 328.76M |
| August 25, 2026 | 330.08M |
| August 24, 2026 | 330.08M |
| August 21, 2026 | 315.56M |
| August 20, 2026 | 310.28M |
| August 19, 2026 | 323.48M |
| August 18, 2026 | 316.88M |
| August 17, 2026 | 315.56M |
| August 14, 2026 | 318.20M |
| August 13, 2026 | 318.20M |
| August 12, 2026 | 316.88M |
| August 11, 2026 | 323.48M |
| August 10, 2026 | 324.80M |
| August 07, 2026 | 326.12M |
| August 06, 2026 | 318.20M |
| August 05, 2026 | 316.88M |
| August 04, 2026 | 322.16M |
| Date | Value |
|---|---|
| August 03, 2026 | 291.79M |
| July 31, 2026 | 287.83M |
| July 30, 2026 | 301.03M |
| July 29, 2026 | 291.79M |
| July 28, 2026 | 305.00M |
| July 27, 2026 | 310.28M |
| July 24, 2026 | 307.64M |
| July 23, 2026 | 307.64M |
| July 22, 2026 | 286.51M |
| July 21, 2026 | 294.43M |
| July 20, 2026 | 294.43M |
| July 17, 2026 | 278.59M |
| July 16, 2026 | 265.39M |
| July 15, 2026 | 271.99M |
| July 14, 2026 | 271.99M |
| July 13, 2026 | 258.78M |
| July 10, 2026 | 269.35M |
| July 09, 2026 | 269.35M |
| July 08, 2026 | 273.31M |
| July 07, 2026 | 270.67M |
| July 06, 2026 | 261.42M |
| July 02, 2026 | 262.74M |
| July 01, 2026 | 256.14M |
| June 30, 2026 | 268.03M |
| June 29, 2026 | 254.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.801B |
| Alnylam Pharmaceuticals, Inc. | 34.20B |
| Anika Therapeutics, Inc. | 280.51M |
| Savara, Inc. | 1.110B |
| Vericel Corp. | 1.991B |
Market Cap Related Metrics
| Price to Book Value | 2.092 |
| Price | 2.43 |
| Earnings Yield | -17.96% |